MSFT   212.47 (-0.17%)
FB   240.21 (-1.38%)
NVDA   410.86 (+0.54%)
CGC   15.79 (-3.31%)
BABA   256.34 (-0.52%)
MU   48.99 (-1.45%)
GE   6.64 (-3.21%)
TSLA   1,362.78 (-0.23%)
T   29.44 (-3.35%)
ACB   11.61 (-4.52%)
F   5.87 (-3.62%)
GILD   74.21 (-1.85%)
DIS   116.00 (-0.57%)
BAC   22.56 (-2.38%)
BA   174.85 (-2.90%)
MSFT   212.47 (-0.17%)
FB   240.21 (-1.38%)
NVDA   410.86 (+0.54%)
CGC   15.79 (-3.31%)
BABA   256.34 (-0.52%)
MU   48.99 (-1.45%)
GE   6.64 (-3.21%)
TSLA   1,362.78 (-0.23%)
T   29.44 (-3.35%)
ACB   11.61 (-4.52%)
F   5.87 (-3.62%)
GILD   74.21 (-1.85%)
DIS   116.00 (-0.57%)
BAC   22.56 (-2.38%)
BA   174.85 (-2.90%)
MSFT   212.47 (-0.17%)
FB   240.21 (-1.38%)
NVDA   410.86 (+0.54%)
CGC   15.79 (-3.31%)
BABA   256.34 (-0.52%)
MU   48.99 (-1.45%)
GE   6.64 (-3.21%)
TSLA   1,362.78 (-0.23%)
T   29.44 (-3.35%)
ACB   11.61 (-4.52%)
F   5.87 (-3.62%)
GILD   74.21 (-1.85%)
DIS   116.00 (-0.57%)
BAC   22.56 (-2.38%)
BA   174.85 (-2.90%)
MSFT   212.47 (-0.17%)
FB   240.21 (-1.38%)
NVDA   410.86 (+0.54%)
CGC   15.79 (-3.31%)
BABA   256.34 (-0.52%)
MU   48.99 (-1.45%)
GE   6.64 (-3.21%)
TSLA   1,362.78 (-0.23%)
T   29.44 (-3.35%)
ACB   11.61 (-4.52%)
F   5.87 (-3.62%)
GILD   74.21 (-1.85%)
DIS   116.00 (-0.57%)
BAC   22.56 (-2.38%)
BA   174.85 (-2.90%)
Log in

Forestar Group (NYSE:FOR) Cut to "Sell" at Zacks Investment Research

Last updated on Monday, June 29th, 2020 by MarketBeat

Forestar Group (NYSE:FOR) was downgraded by Zacks Investment Research from a "hold" rating to a "sell" rating in a research note issued to investors on Monday, Zacks.com reports.

According to Zacks, "Forestar Group, Inc. formerly known as Forestar Real Estate Group Inc. operates in two business segments: real estate and natural resources. The real estate segment owns directly or through ventures real estate. The natural resources segment manages acres of oil and gas mineral interests. In addition, the company also sells wood fiber from its land primarily located in Georgia, and leases land for recreational uses. "

Other equities research analysts have also issued research reports about the company. TheStreet upgraded Forestar Group from a "d+" rating to a "c-" rating in a research report on Tuesday, June 9th. Citigroup began coverage on Forestar Group in a research report on Wednesday, April 29th. They set a "buy" rating and a $16.00 price objective on the stock. BTIG Research reduced their price objective on Forestar Group from $26.00 to $19.00 and set a "buy" rating on the stock in a research report on Monday, April 27th. Wells Fargo & Co reduced their price target on Forestar Group from $25.00 to $14.00 in a research report on Monday, April 27th. Finally, JPMorgan Chase & Co. reduced their price target on Forestar Group from $22.00 to $12.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 28th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of "Hold" and an average price target of $17.00.

FOR stock traded up $0.10 during midday trading on Monday, reaching $14.69. 224,210 shares of the stock were exchanged, compared to its average volume of 136,130. The stock has a market capitalization of $700.85 million, a PE ratio of 14.54, a P/E/G ratio of 11.76 and a beta of 2.15. Forestar Group has a 52 week low of $9.43 and a 52 week high of $23.11. The company has a debt-to-equity ratio of 0.76, a current ratio of 4.49 and a quick ratio of 4.49. The company has a fifty day moving average price of $14.84 and a 200 day moving average price of $16.67.

Forestar Group (NYSE:FOR) last issued its quarterly earnings data on Thursday, April 23rd. The oil and gas exploration company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The business had revenue of $159.10 million for the quarter, compared to analyst estimates of $159.10 million. Forestar Group had a return on equity of 5.82% and a net margin of 6.31%. As a group, analysts anticipate that Forestar Group will post 0.85 earnings per share for the current fiscal year.

In related news, CFO James Douglas Allen purchased 5,200 shares of Forestar Group stock in a transaction on Friday, June 12th. The shares were purchased at an average price of $14.41 per share, for a total transaction of $74,932.00. Following the transaction, the chief financial officer now owns 5,200 shares of the company's stock, valued at approximately $74,932. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.14% of the company's stock.

Large investors have recently made changes to their positions in the company. State Street Corp lifted its stake in shares of Forestar Group by 59.7% in the 1st quarter. State Street Corp now owns 284,711 shares of the oil and gas exploration company's stock valued at $2,947,000 after purchasing an additional 106,404 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Forestar Group by 45.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 89,570 shares of the oil and gas exploration company's stock worth $1,868,000 after buying an additional 28,117 shares during the period. Aperio Group LLC raised its stake in Forestar Group by 40.4% during the 1st quarter. Aperio Group LLC now owns 14,650 shares of the oil and gas exploration company's stock worth $152,000 after buying an additional 4,218 shares during the period. Heartland Advisors Inc. raised its stake in Forestar Group by 4.3% during the 4th quarter. Heartland Advisors Inc. now owns 174,016 shares of the oil and gas exploration company's stock worth $3,628,000 after buying an additional 7,113 shares during the period. Finally, Mackay Shields LLC acquired a new position in Forestar Group during the 1st quarter worth approximately $906,000. 31.54% of the stock is currently owned by institutional investors.

Forestar Group Company Profile

Forestar Group Inc operates as a real estate lot development company. It engages in the acquisition, entitlement, and development of infrastructure for single-family residential communities. Forestar Group Inc sells residential lots primarily to homebuilders, as well as sells commercial properties. The company is headquartered in Austin, Texas.

Recommended Story: How can investors benefit from after-hours trading?

Get a free copy of the Zacks research report on Forestar Group (FOR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

8 Pharmaceutical Companies Working on a Coronavirus Cure

We are living through interesting times. Not an hour goes by when Americans don’t receive some reminder of the impact the coronavirus has on our lives. The race is on for an effective, FDA-approved treatment for the virus. Despite, vaccines being available for human trial in record time, we are many months away from having a viable vaccine.

However, we may be somewhat closer in finding some antiviral treatments. And if you’ve watched the market closely this week, any news on that front tends to move the market in a positive direction.

That brings up another truth of investing. There are some stocks that thrive from other stocks misery. And that’s why we’ve put together this special report. If you’re an investor who is looking to jump into this bear market, the pharmaceutical sector is a logical choice.

A combination of big-name drug companies as well as smaller startup companies are working around the clock to develop vaccines or treatments that will target the infection caused by the novel coronavirus.

View the "8 Pharmaceutical Companies Working on a Coronavirus Cure".

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.